Your browser doesn't support javascript.
Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients.
Sigler, Rachel; Chen, Victor; Law, Nancy.
  • Sigler R; Division of Infectious Diseases and Global Public Health, University of California San Diego, 9444 Medical Center Drive, MC 0879, La Jolla, CA 92093-0879 USA.
  • Chen V; Department of Pharmacy, University of California San Diego, La Jolla, CA USA.
  • Law N; Division of Infectious Diseases and Global Public Health, University of California San Diego, 9444 Medical Center Drive, MC 0879, La Jolla, CA 92093-0879 USA.
Curr Transplant Rep ; 9(3): 185-198, 2022.
Article in English | MEDLINE | ID: covidwho-1943554
ABSTRACT
Purpose of Review In this review, we aim to summarize the evolution of care for the solid organ transplant recipient (SOTR) with COVID-19 disease, based on the current published guidelines and our center's experience. Recent

Findings:

Oral antiviral medications and monoclonal antibodies are now used with the goal to prevent severe disease. Immunomodulating drugs in addition to antivirals have been used in the treatment of severe COVID-19.

Summary:

With the ongoing pandemic and unique challenges posed by the SOTR, understanding the risk and advancing management and treatment of COVID-19 infections are imperative to the successful care of a transplant recipient. There are many ongoing clinical trials being conducted in hopes of developing novel therapeutics towards COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Curr Transplant Rep Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Curr Transplant Rep Year: 2022 Document Type: Article